Biocon Biologics biosimilar available in US, to treat inflammatory diseases
Biocon Biologics, a subsidiary of Biocon, said Monday that its biosimilars for treating certain inflammatory diseases are now available on
Continue readingThe Number One Finance & Business Blog!
Biocon Biologics, a subsidiary of Biocon, said Monday that its biosimilars for treating certain inflammatory diseases are now available on
Continue readingboard of directors Central Bank of India Approved to raise the combined share capital up to Rs 2,500 crore within
Continue reading